Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~40 mi. (Saint-Herblain, France, +226 more cities)
facility
Institut De Cancerologie De L Ouest ( Site 0448)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)
city
~40 mi. (Saint-Herblain, France, +45 more cities)
facility
Institut De Cancerologie De L Ouest ( Site 1003)
drug
cisplatin, +5 more drugs
drug type
chemotherapy, +2 more types
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
city
~40 mi. (Saint-Herblain, France, +122 more cities)
facility
Institut De Cancerologie De L Ouest ( Site 1110)
drug
etoposide, +5 more drugs
drug type
chemotherapy, +3 more types
Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
city
~40 mi. (Saint-Herblain, France, +105 more cities)
facility
Institut de Cancerologie de l Ouest Centre Rene Gauducheau ( Site 0455)
drug
bevacizumab, +1 more drug
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
city
~40 mi. (Saint-Herblain, France, +24 more cities)
facility
Institut de Cancérologie de l'Ouest René Gauducheau /ID# 212880
biomarker
ER Negative, +2 more biomarkers
condition
Breast Adenocarcinoma, +2 more conditions
drug
ABBV-368, +5 more drugs
drug type
chemotherapy, +1 more type
Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure
city
~40 mi. (Saint-Herblain, France, +7 more cities)
facility
ICO Centre René Gauducheau
drug
lenvatinib, +1 more drug
drug type
Other, +1 more type
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~45 mi. (Nantes, France, +176 more cities)
facility
Hopital prive du Confluent ( Site 2061)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
city
~45 mi. (Nantes, France, +163 more cities)
facility
CHU Hotel Dieu Nantes ( Site 0458)
drug
cystectomy, +2 more drugs
drug type
chemotherapy, +3 more types